See α-Synuclein. Candidate tracer SY08 detects α-synuclein deposits in the brainstem (right) and parietal cortex (left) of people with Parkinson’s (middle) and dementia with Lewy bodies (bottom), but ...

A study by HE Zhuohao's team from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences, along with collaborators, has revealed the critical role of the "fuzzy coat" of ...

Researchers visualize α-synuclein pathology in living patients with a neurodegenerative disorder The National Institutes for Quantum Science and Technology Journal Movement Disorders DOI 10.1002 ...

Parkinson’s disease (PD) is a neurodegenerative disease of the central nervous system characterized by the loss of dopaminergic neurons in the substantia nigra and the abnormal aggregation of ...

The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease (PD) and anti-tau therapies, which are ...